Care and disease management programs and tools are ubiquitous. A study in the Journal of General Internal Medicine considers whether ones directed by health plans or providers have greater success, if any. (JGIM Article) In theory, provider-operated disease management might have more success, since it is inherently integrated with primary care. The study compared in one health plan over 2010 to 2012, disease management programs operated by the plan’s staff for congestive heart failure, chronic obstructive pulmonary disease, coronary heart disease, diabetes and asthma, versus those operated by four physician groups consisting of 31 primary care practices and funded by the health plan. The programs did not have identical features, but were broadly similar. A pre-post design was used to analyze impacts. Outcomes included cholesterol levels, weight management, blood pressure, and blood sugar control. Data from around 4000 patients was included in the analysis. There was modest improvement in most outcome measures for both groups. The provider-directed care management programs did somewhat better on some measures and the health plan programs did somewhat better on others, but none of the differences reached statistical significance. Both programs accomplished getting some additional patients engaged in a program. Many of the patients, although suffering from one of the chronic diseases, already had outcome measures that were within goals, making further improvement difficult. There was a savings in overall health expenditures among both groups, but these savings were not compared to the costs of the programs. The general lack of substantial improvement in outcome measures is not encouraging for disease management programs generally, and is consistent with some other research, but it is good to find that both health plan and provider-operated disease management programs appear to have some effectiveness.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
NextGen, an electronic medical records firm, is being put out of its public company misery, as a PE firm will pay $1.6 billion for the one-time high-flier.
September 7, 2023
A number of companies which attracted large financing rounds during the epidemic have imploded when reality set in. The latest is Cano Health, which is a little surprising since it...
August 15, 2023
Another over-hyped digital health company screws shareholders who bought the hype, as Babylon Health has to bail itself out by going private, with nothing being returned to ordinary shareholders. The...
June 26, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace